Page last updated: 2024-11-02

pirenzepine and Autoimmune Thrombocytopenia

pirenzepine has been researched along with Autoimmune Thrombocytopenia in 1 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bachmann, S1
Schröder, J1
Pantel, J1
Mundt, C1
Zorn, M1
Witzens, M1
Egerer, G1

Other Studies

1 other study available for pirenzepine and Autoimmune Thrombocytopenia

ArticleYear
Olanzapine-induced thrombocytopenia in association with idiopathic thrombocytopenic purpura.
    The British journal of psychiatry : the journal of mental science, 1998, Volume: 173

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Olanzapine; Pirenzepine; Purpura, Thro

1998